Deal Law Wire

APRIL 1, 2021

The recent economic volatility has also seen an increase in the use of alternatives to one-time cash purchases in the context of M&A deals , including earnouts and working capital adjustments. By adjusting the purchase price to either account for or depend on future milestones, parties are more likely to come to an agreement.

M&A 40

M&A Funds Accountant IT 40

Intrepid Banker Insights

MARCH 28, 2023

Intrepid Investment Bankers Warning Signs Your Business’s Liquidity Needs Attention Mixed signals dominate economic headlines as concerns persist about a recession beginning in 2023, if it has not already begun. At the same time, employment remains strong, with the unemployment rate hitting an all-time low.

Capital 52

Capital Advisory Bank Banking 52

Cooley M&A

MARCH 1, 2019

These include prevailing market sentiment, current appetite for acquisitions in a particular sector and the political and economic environment, all of which can change well within a given transaction timetable. The usual pros and cons of being a publicly traded company will also need to be considered. What’s the time frame?

IPO 52

IPO Valuation M&A Business 52

Wall Street Mojo

FEBRUARY 9, 2024

When listed as publicly traded companies, they mostly become small-cap and micro-cap stocks trading on the exchange. Such firms enjoy high growth rates and play a vital economic role. In contrast, the upper middle market segment only accounts for 1% of the market. Even capital assets are used in this form of borrowing. #3

Middle Market 52

Middle Market Bulge Bracket Private Equity Investment Banking 52

RKJ Partners

AUGUST 6, 2017

To be more specific, business valuation is a process involving a set of procedures and approaches used to gauge the economic value of an ownership interest in a business as a going concern. The advantage of this method is that it takes into account the development of the company, rather than simply the historical financials.

M&A 40

M&A Valuation Mergers and Acquisitions Discounted Cash Flow 40

Software Equity Group

OCTOBER 22, 2024

In today’s economic climate, retention is everything: Software companies with Net Revenue Retention (NRR) rates above 120% are trading at a remarkable 63% premium over the market median. Effective Upsell and Cross-Sell Tactics The top performers excel at expanding their footprint within existing accounts.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

SEPTEMBER 16, 2022

In addition, currently public dual-class companies with transfer provisions that do not contain clear carve outs for the delivery of voting agreements in the M&A context should discuss with their advisers the possibility of adopting “clear day” amendments to their charters to include these carve outs. Vote-down termination fee (i.e.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Mergers and Inquisitions

DECEMBER 4, 2024

No matter the economic climate, you can always bet on sports fans to show up for their favorite teams. However, one common point across all the verticals is that IPOs are not common because there aren’t that many publicly traded sports teams, stadiums, or arenas.

Investment Banking 105

Investment Banking Banking Bank Investment 105

Cooley M&A

JANUARY 22, 2021

While the decision was case-specific, we were all reminded of (i) the high bar of the MAE, particularly when changes are attributable to a systemic risk and (ii) the increasingly important role that covenants play with respect to deal certainty, particularly in periods of market and economic uncertainty. Buyer…Seller…PPP Lender? A Look Ahead.

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Cooley M&A

JANUARY 20, 2022

Private equity’s increased interest in life sciences , with PE buyers accounting for 47% of deal volume in the first half of 2021 , compared to a long?term 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 billion in a bid to acquire cutting edge research capabilities.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40